2015 VAM: 3302 - EAACI: Bringing Molecular Diagnosis and Treatment Closer to the Bedside: European Trials

This recording will describe new developments in the use of molecular components in diagnosis and treatment of different allergic diseases. It is intended for both clinicians and basic scientists. **Alt. moderator TBA; EAACI President-Elect, decided in June.

AMA PRA Category 1 Credits™: 1.25
CE 1.25

Credit must be claimed by June 30, 2017.  Any credit request on or after July 1, 2017 will be subject to an administrative fee.

System requirements: Two most recent versions of Internet Explorer, Safari, Google Chrome, and Firefox

Target Audience

Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals

 

Learning Objectives

Upon completion of this activity, participants will be able to:
1.  Recognize and discuss the advances in the use of modified allergens for immunotherapy
2.  Describe the potential of and use for a chip measuring rhinovirus exposure in relation to respiratory allergy activity and exacerbations
3.  Identify the usefulness of molecular components for food allergy diagnosis

Summary
Available credit: 
  • 1.25 Attendance
    Attendance credit.
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.
Course opens: 
11/24/2015
Course expires: 
06/30/2017
Cost:
$15.00

Prof. Lars K. Poulsen, PhD FAAAAI, Copenhagen University Hospital, Hellerup, Denmark

Prof. Rudolf Valenta, MD, Medical University of Vienna AKH, Wien, Austria

Prof. Ronald Van Ree, PhD FAAAAI, Academic Medical Centre, University of Amsterdam

Available Credit

  • 1.25 Attendance
    Attendance credit.
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.

Accreditation Period

Course opens: 
11/24/2015
Course expires: 
06/30/2017

Price

Cost:
$15.00
Please login or register to take this course.